Insider sale details
Donald P. Richmond II, the Chief Technology Officer of Aehr Test Systems (NASDAQ: AEHR), executed a sale of 17,011 common shares on April 14, 2026, according to a Form 4 filing with the Securities and Exchange Commission. The shares traded at $73.1764 apiece, producing proceeds of $1,244,803 for the transaction.
Current trading context
The sale coincided with AEHR trading near its 52-week high of $74.72, approximately 1% below that high-water mark. Over the past year the equity has delivered an exceptional return of 771%. At the time of the filing the stock quoted at $73.26, which implies a market capitalization of $2.29 billion.
Valuation and revenue trends
InvestingPro analysis flags AEHR as appearing overvalued versus its Fair Value assessment. That view is noted alongside the company’s elevated revenue valuation multiple, even as reported revenue declined 26% to $45.26 million. These valuation metrics are highlighted as a point of concern in light of recent financial performance.
Post-sale ownership and research access
Following the disposition, Richmond still directly holds 181,512 shares of Aehr Test Systems common stock. That total includes shares that remain subject to unvested restricted stock units. For investors seeking further detail on valuation and financial metrics, a Pro Research Report covering AEHR and more than 1,400 other U.S. stocks is available on InvestingPro.
Recent operating performance
Aehr Test Systems disclosed mixed results for its fiscal Q3 2026. The company reported an earnings per share of -$0.05, outperforming the consensus forecast of -$0.07. Revenue came in at $10.3 million, short of the expected $10.8 million. Offsetting the revenue shortfall, management reported record quarterly bookings of $37.2 million, and an effective backlog that now exceeds $50 million, indicating an acceleration in demand metrics.
Analyst reactions
Following the quarterly update, analyst firm Freedom Broker raised its price target for Aehr Test Systems to $61 while maintaining a Hold rating. Lake Street increased its price target to $56 and kept a Buy rating, citing momentum in bookings as the rationale for its outlook. These adjustments reflect continuing analyst attention to the company’s order book and bookings trends.
Bottom line
The insider sale by Aehr’s CTO occurred against a backdrop of a sharply higher share price, mixed quarterly results, and strong bookings. Richmond’s remaining stake remains substantial, and analysts have updated their targets based on recent demand indicators.